PDCD1 and COVID-19: The expression of negative immune checkpoint molecules on CD8+ and CD4+ T cells examined in 14 individuals with severe COVID-19 revealed an increased abundance of PD-1 and TIM-3 levels in most severe COVID-19 cases (20).